Publication | Closed Access
Recombinant Tissue Factor Pathway Inhibitor in Severe Community-acquired Pneumonia
126
Citations
31
References
2011
Year
Tifacogin showed no mortality benefit in patients with sCAP despite evidence of biologic activity.
| Year | Citations | |
|---|---|---|
Page 1
Page 1